Top Wall Street Forecasters Revamp DocuSign Price Expectations Ahead Of Q4 Earnings

Benzinga
2025/03/13

DocuSign, Inc. (NASDAQ:DOCU) will release its fourth-quarter financial results, after the closing bell, on Thursday, March 13.

Analysts expect the San Francisco, California-based company to report quarterly earnings at 85 cents per share, up from 76 cents per share in the year-ago period. DocuSign projects quarterly revenue of $761.64 million, compared to $712.39 million a year earlier, according to data from Benzinga Pro.

On Dec. 5, 2024, DocuSign reported third-quarter revenue of $754.8 million, beating the consensus estimate of $745.26 million.

DocuSign shares rose 0.8% to close at $80.13 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • JP Morgan analyst Mark Murphy upgraded the stock from Underweight to Neutral and raised the price target from $70 to $75 on March 10, 2025. This analyst has an accuracy rate of 73%.
  • JMP Securities analyst Patrick Walravens reiterated a Market Outperform rating with a price target of $124 on Jan. 7, 2025. This analyst has an accuracy rate of 61%.
  • HSBC analyst Stephen Bersey downgraded the stock from Hold to Reduce on Dec. 6, 2024. This analyst has an accuracy rate of 61%.
  • Citigroup analyst Tyler Radke maintained a Buy rating and raised the price target from $87 to $113 on Dec. 6, 2024. This analyst has an accuracy rate of 66%.
  • UBS analyst Karl Keirstead maintained a Neutral rating and increased the price target from $60 to $100 on Dec. 6, 2024. This analyst has an accuracy rate of 74%.

Considering buying DOCU stock? Here’s what analysts think:

Read This Next:

  • Top 2 Industrials Stocks That May Collapse In March

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10